Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Munehiro Ito
Institution:
National Hospital Organization Saitama Hospital
Observed institutions:
Kyoto University,
National Cancer Centre Japan,
Kobe City Medical Center General Hospital,
National Hospital Organization Saitama Hospital,
National Cancer Center Hospital
ORCID:
0009-0008-4751-6094
Observed ORCID:
0009-0008-4751-6094
OpenAlex ID:
A5102268181
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
2017
·
Shunsuke Teraoka
, Daichi Fujimoto
, et al.
·
Journal of Thoracic Oncology
·
400
PDF
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
2017
·
Daichi Fujimoto
, Keiichiro Uehara
, et al.
·
Scientific Reports
·
92
PDF
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia
2017
·
Daichi Fujimoto
, Takeshi Morimoto
, et al.
·
Lung Cancer
·
81
Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non–Small Cell Lung Cancer
2017
·
Daichi Fujimoto
, Yuki Sato
, et al.
·
Journal of Thoracic Oncology
·
62
Clinical Characteristics and Prognosis of Patients With Advanced Non–Small-cell Lung Cancer Who Are Ineligible for Clinical Trials
2018
·
Hayato Kawachi
, Daichi Fujimoto
, et al.
·
Clinical Lung Cancer
·
46
Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis
2019
·
Satoru Fujiwara
, Naoya Mimura
, et al.
·
Internal Medicine
·
21
PDF
Programmed Cell Death Ligand 1 Expression in Non–Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study
2018
·
Daichi Fujimoto
, Yuki Sato
, et al.
·
Clinical Lung Cancer
·
13
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patient
2020
·
Munehiro Ito
, Shintaro Kanda
, et al.
·
Lung Cancer
·
10
Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature
2017
·
Ryobu Mori
, Daichi Fujimoto
, et al.
·
Oncotarget
·
10
PDF
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
2024
·
Rui Kitadai
, Tatsunori Shimoi
, et al.
·
Breast Cancer
·
4
PDF
Abstract PO3-15-12: Expression and co-expression patterns of TROP2 and HER2 in breast cancer: implications for bispecific antibody-drug conjugate therapy
2024
·
Mai Onishi
, Tatsunori Shimoi
, et al.
·
Cancer Research
·
4
Loss of body weight during neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil as predictive of poor survival of patients with esophageal squamous cell carcinoma.
2020
·
Munehiro Ito
, Ken Kato
, et al.
·
Journal of Clinical Oncology
·
4
Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report
2020
·
Munehiro Ito
, Yutaka Fujiwara
, et al.
·
Frontiers in Oncology
·
3
PDF
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test
2025
·
Rumi Nishimura
, Kazuki Sudo
, et al.
·
Oncology
·
1
Abstract 975: Genomic landscape of circulating tumor DNA in cervical cancer in Asia: NCCH1905/A-TRAIN trial
2024
·
Prathepamalar Yehgambaram
, Yuki Kojima
, et al.
·
Cancer Research
·
1
Intolarence of pirfenidone and its associated factors in the real world
2016
·
Shunsuke Teraoka
, Daichi Fujimoto
, et al.
·
European Respiratory Journal
·
1
Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study
2026
·
Kazuki Yokoyama
, Kazunori Honda
, et al.
·
Japanese Journal of Clinical Oncology
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer
2025
·
Mai Hoshino
, Tatsunori Shimoi
, et al.
·
Breast Cancer
PDF
Abstract P3-05-24: Mapping the Genomic Landscape: Comprehensive Profiling of Diverse Histological Types of Breast Cancer
2025
·
Taro Yamanaka
, Tatsunori Shimoi
, et al.
·
Clinical Cancer Research
Abstract P2-05-26: Differential TROP2 expression patterns among inflamed tumor microenvironments in HER2-negative breast cancer
2025
·
Mai Onishi
, Tatsunori Shimoi
, et al.
·
Clinical Cancer Research
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum‐Based Therapy
2025
·
Tomomi Sanomachi
, Tatsunori Shimoi
, et al.
·
Head & Neck
PDF
Abstract 2034: Investigation of TROP2 expression and immune microenvironment in ovarian clear cell carcinoma
2025
·
Toru Imai
, Yuki Kojima
, et al.
·
Cancer Research
Evaluation of the 4-meter gait speed (4mGS) in patients with interstitial pneumonia: a prospective observational study.
2018
·
Ryosuke Hirabayashi
, Yusuke Takahashi
, et al.
·
European Respiratory Journal
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
2018
·
Ryobu Mori
, Mariko Kogo
, et al.
·
European Respiratory Journal
Clinical role of CT scan-measured pulmonary artery to aorta ratio of acute exacerbation of interstitial lung disease
2017
·
Mariko Kogo
, Kojiro Otsuka
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
26
Citation count:
753
H-index:
9
I10-index:
9
Year
Topic
Type